{"id":814452,"date":"2025-02-18T16:37:03","date_gmt":"2025-02-18T21:37:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/"},"modified":"2025-02-18T16:37:03","modified_gmt":"2025-02-18T21:37:03","slug":"illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/","title":{"rendered":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">SAN DIEGO<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 18, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.\u00a0<\/p>\n<p>The investor fireside chat will begin at <span class=\"xn-chron\">8:00am Pacific Time<\/span> (<span class=\"xn-chron\">11:00am Eastern Time<\/span>) on <span class=\"xn-chron\">Tuesday, February 25, 2025<\/span> and will feature <span class=\"xn-person\">Jacob Thaysen<\/span> (Chief Executive Officer), <span class=\"xn-person\">Ankur Dhingra<\/span> (Chief Financial Officer), and <span class=\"xn-person\">Steve Barnard<\/span> (Chief Technology Officer).<\/p>\n<p>Interested parties may access the live webcast via the Investor Info section of Illumina&#8217;s website or directly through the following <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=3588452395&amp;u=https%3A%2F%2Fillumina-agbt-investor-session-feb-2025.open-exchange.net%2F&amp;a=link\" target=\"_blank\" rel=\"nofollow\">link<\/a> \u2013 (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=512110763&amp;u=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2Fillumina-agbt-investor-session-feb-2025.open-exchange.net%2F__%3B!!HrbR-XT-OQ!R1IZWZdFlMChAscE3n7hcV8KPAwfaKqrx6OHH5Ejn7PqbU2vMmeEQQpzLElOXwTzUbiWAfWt6SU4jrcVV7EKJaADHcdMIA%24&amp;a=https%3A%2F%2Fillumina-agbt-investor-session-feb-2025.open-exchange.net%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/illumina-agbt-investor-session-feb-2025.open-exchange.net\/<\/a>) To ensure timely connection, please join at least ten minutes before the scheduled start of the session.<\/p>\n<p>A replay will be posted on Illumina&#8217;s website after the event and will be available for at least 30 days following.<\/p>\n<p>\n        <b>About Illumina<\/b>\n      <\/p>\n<p>Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=1853669929&amp;u=https%3A%2F%2Fwww.illumina.com%2F&amp;a=www.illumina.com\" target=\"_blank\" rel=\"nofollow\">www.illumina.com<\/a><\/u> and connect with us on\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=1130199663&amp;u=https%3A%2F%2Ftwitter.com%2Fillumina&amp;a=X+(Twitter)\" target=\"_blank\" rel=\"nofollow\">X (Twitter)<\/a><\/u>,\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=795806993&amp;u=https%3A%2F%2Fwww.facebook.com%2Filluminainc&amp;a=Facebook\" target=\"_blank\" rel=\"nofollow\">Facebook<\/a><\/u>,\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=2713708310&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fillumina&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/u>,\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=3248368500&amp;u=https%3A%2F%2Fwww.instagram.com%2Filluminainc&amp;a=Instagram\" target=\"_blank\" rel=\"nofollow\">Instagram<\/a><\/u>,\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=3689642023&amp;u=https%3A%2F%2Fwww.tiktok.com%2F%40illuminainc&amp;a=TikTok\" target=\"_blank\" rel=\"nofollow\">TikTok<\/a><\/u>,\u00a0and\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4364970-1&amp;h=1148194329&amp;u=https%3A%2F%2Fwww.youtube.com%2Fuser%2FIlluminaInc&amp;a=YouTube\" target=\"_blank\" rel=\"nofollow\">YouTube<\/a><\/u>.<\/p>\n<p>Investors:\u00a0<br \/>Salli Schwartz\u00a0<br \/>+1.858.291.6421 <br \/><a href=\"mailto:ir@illumina.com\" target=\"_blank\" rel=\"nofollow\">ir@illumina.com<\/a>\u00a0<\/p>\n<p>Media:<br \/><span class=\"xn-person\">Bonny Fowler<\/span><br \/>+1.740.641.5579<br \/><a href=\"mailto:pr@illumina.com\" target=\"_blank\" rel=\"nofollow\">pr@illumina.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference-302379336.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference-302379336.html<\/a><\/p>\n<p>SOURCE  Illumina, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA21757&amp;Transmission_Id=202502181605PR_NEWS_USPR_____LA21757&amp;DateId=20250218\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO , Feb. 18, 2025 \/PRNewswire\/ &#8212; Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.\u00a0 The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer). Interested parties may access the live webcast via the Investor Info section of Illumina&#8217;s website or directly through the following link \u2013 (https:\/\/illumina-agbt-investor-session-feb-2025.open-exchange.net\/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session. A replay will be posted on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-814452","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO , Feb. 18, 2025 \/PRNewswire\/ &#8212; Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.\u00a0 The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer). Interested parties may access the live webcast via the Investor Info section of Illumina&#8217;s website or directly through the following link \u2013 (https:\/\/illumina-agbt-investor-session-feb-2025.open-exchange.net\/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session. A replay will be posted on &hellip; Continue reading &quot;Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-18T21:37:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference\",\"datePublished\":\"2025-02-18T21:37:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA21757&amp;sd=2025-02-18\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/\",\"name\":\"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA21757&amp;sd=2025-02-18\",\"datePublished\":\"2025-02-18T21:37:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA21757&amp;sd=2025-02-18\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA21757&amp;sd=2025-02-18\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/","og_locale":"en_US","og_type":"article","og_title":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk","og_description":"PR Newswire SAN DIEGO , Feb. 18, 2025 \/PRNewswire\/ &#8212; Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.\u00a0 The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer). Interested parties may access the live webcast via the Investor Info section of Illumina&#8217;s website or directly through the following link \u2013 (https:\/\/illumina-agbt-investor-session-feb-2025.open-exchange.net\/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session. A replay will be posted on &hellip; Continue reading \"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-18T21:37:03+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference","datePublished":"2025-02-18T21:37:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/","name":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18","datePublished":"2025-02-18T21:37:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA21757&amp;sd=2025-02-18"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=814452"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/814452\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=814452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=814452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=814452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}